Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 23 peer-reviewed journal articles Updated
Pulmonology

Treatment Strategies: The Path to Clearing the Infection

At a Glance

The primary goal of pleural empyema treatment is source control to drain pus from the chest. Doctors use a step-up approach, starting with antibiotics and a chest tube. If the infection forms thick pockets, injected medications (tPA and DNase) or minimally invasive VATS surgery are used to clean the space.

Treating pleural empyema is a race against time. Because the infection naturally progresses from a simple fluid to a thick, leathery “peel” (see Understanding Pleural Empyema), doctors use a step-up approach [1][2]. The goal is always the same: source control. This means physically removing the infected fluid and pus so the lung can re-expand and antibiotics can finish the job [1][3].

The “Step-Up” Roadmap

Most patients begin at the bottom of this “ladder” and only move up if the current step isn’t working [1].

  1. Antibiotics + Simple Drainage (Stage I): For early infections where the fluid is thin, a small chest tube (a plastic tube inserted between the ribs) combined with IV antibiotics is often enough to clear the space [4][5].
  2. Intrapleural Medications (Stage II): If the fluid has started to form pockets (loculations), doctors may inject medications called tPA and DNase directly into the chest tube [6]. Think of these as microscopic scissors; they work together to gently cut through the thick fibrin webs and thin out the pus so it can drain through the tube [7][8]. Safety Note: Because tPA is a clot-buster medication, there is a small risk of bleeding in the chest, which your care team will monitor closely [9].
  3. VATS Surgery (Stage II / Early Stage III): If medications don’t work, or if the infection is already too thick, Video-Assisted Thoracoscopic Surgery (VATS) is the next step [10]. This is a minimally invasive surgery where a surgeon uses a tiny camera and small instruments to physically break up the pockets and clean out the pleural space [11][12].
  4. Open Decortication (Advanced Stage III): In chronic cases where a thick “rind” or pleural peel has encased the lung like shrink-wrap, an open surgery (thoracotomy) may be required [4][11]. The surgeon manually peels away the leathery layer to allow the lung to breathe again [13].

Managing Your Pain and Comfort

Having a plastic tube placed between your ribs is uncomfortable, and the thought of surgery can be scary. Managing your pain is a critical part of your treatment. If you are in pain, you will have trouble taking deep breaths, which can slow down your recovery [14]. Your care team will use a combination of medications—often including local anesthetics, nerve blocks, or oral pain relievers—to ensure you can move, cough, and breathe comfortably while the tube is in place or after surgery [15]. Never hesitate to tell your nurse if your pain is not well controlled.

Why Early Intervention is Critical

The longer the infection sits in the chest, the more difficult it is to treat [16].

  • Preventing Permanent Damage: If the “peel” is left too long, it can lead to permanent lung scarring or lung entrapment, where the lung can never fully expand again [17][11].
  • Lowering Surgical Risk: VATS is much easier to perform in the early-to-mid stages. In advanced Stage III, the risk of needing to convert from a small-incision VATS to a large-incision open surgery increases significantly [18][19].
  • Faster Recovery: Patients who receive timely drainage or early VATS typically have shorter hospital stays and fewer complications [20][21].

When to Escalate Treatment

You and your care team should watch for signs that the current treatment is “failing.” Failure is usually defined by [22][23]:

  • Persistent Fever: Still having high fevers after 48–72 hours of drainage and antibiotics.
  • Stalled Drainage: The chest tube stops draining, but imaging shows there is still a large amount of fluid left.
  • Rising Lab Markers: Blood tests like C-reactive protein (CRP) remain high or continue to rise despite treatment [22].

If these signs appear, it is often a signal that it is time to move to the next “step” in the treatment plan. You can learn more about how doctors predict your hospital timeline in Prognosis and Recovery.

Common questions in this guide

How is pleural empyema treated?
Treatment follows a step-up approach focused on draining the infection. Doctors usually start with antibiotics and a chest tube. If the fluid is too thick to drain, they may use medications to break it up or perform minimally invasive surgery to clean out the chest cavity.
What are tPA and DNase medications used for?
These medications are injected directly into a chest tube to help break up thick pockets of infection. They act like microscopic scissors to thin out the pus so it can drain more easily. While highly effective, there is a small risk of bleeding that your care team will monitor.
When is VATS surgery needed for pleural empyema?
VATS is typically recommended when chest tubes and medications are not enough to clear the infection. During this minimally invasive procedure, a surgeon uses a tiny camera and instruments to physically break up infected pockets and clean out the pleural space.
What is a pleural peel?
A pleural peel is a thick, leathery layer of scar tissue that can encase the lung in advanced stages of empyema. This peel acts like shrink-wrap and prevents the lung from fully expanding. Surgeons can remove this layer through an open surgery called decortication to help you breathe normally again.
How do doctors know if my chest tube isn't working?
Doctors monitor several signs to see if treatment is working. If you still have high fevers after a few days, if the chest tube stops draining but fluid remains on imaging, or if your blood inflammatory markers stay high, your care team may move to the next step in treatment.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Is my infection currently responding to the 'step-up' approach, or do we need to consider surgery like VATS now?
  2. 2.What are the risks of bleeding associated with using intrapleural tPA/DNase in my specific case?
  3. 3.Does my latest CT scan show 'lung entrapment' or a thick pleural peel that might make a chest tube less effective?
  4. 4.What is your plan for keeping my pain under control while the chest tube is in place?
  5. 5.Is a VATS procedure feasible for me, or is the infection advanced enough that I might need an open decortication?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (23)
  1. 1

    Evaluation and management of pleural sepsis.

    Lui JK, Billatos E, Schembri F

    Respiratory medicine 2021; (187()):106553 doi:10.1016/j.rmed.2021.106553.

    PMID: 34340174
  2. 2

    Repeated therapeutic thoracentesis to manage complicated parapneumonic effusions.

    Jouneau S, Letheulle J, Desrues B

    Current opinion in pulmonary medicine 2015; (21(4)):387-92 doi:10.1097/MCP.0000000000000171.

    PMID: 26016584
  3. 3

    More isn't always better: antibiotic duration after surgical decortication in pleural empyema.

    Freudenberger DC, Scheese D, Wolfe LG, et al.

    Journal of thoracic disease 2024; (16(6)):3873-3881 doi:10.21037/jtd-24-61.

    PMID: 38983133
  4. 4

    Stage-directed therapy of pleural empyema.

    Reichert M, Hecker M, Witte B, et al.

    Langenbeck's archives of surgery 2017; (402(1)):15-26 doi:10.1007/s00423-016-1498-9.

    PMID: 27815709
  5. 5

    Management of Empyema Thoracis in Low-Resource Settings.

    Bekele A, Alayande BT

    Thoracic surgery clinics 2022; (32(3)):361-372 doi:10.1016/j.thorsurg.2022.02.004.

    PMID: 35961744
  6. 6

    Effectiveness of Intrapleural Tissue Plasminogen Activator and Dornase Alfa vs Tissue Plasminogen Activator Alone in Children with Pleural Empyema: A Randomized Clinical Trial.

    Livingston MH, Mahant S, Connolly B, et al.

    JAMA pediatrics 2020; (174(4)):332-340 doi:10.1001/jamapediatrics.2019.5863.

    PMID: 32011642
  7. 7

    Management of Intrapleural Sepsis with Once Daily Use of Tissue Plasminogen Activator and Deoxyribonuclease.

    Mehta HJ, Biswas A, Penley AM, et al.

    Respiration; international review of thoracic diseases 2016; (91(2)):101-6 doi:10.1159/000443334.

    PMID: 26761711
  8. 8

    New insights into the management of complicated pneumonia in children: A systematic review of randomized controlled trials.

    Tzoni G, Dimopoulou A, Dimopoulou D

    Journal of pediatric surgery 2025; (61(1)):162737 doi:10.1016/j.jpedsurg.2025.162737.

    PMID: 41109518
  9. 9

    Dual intracavitary therapy for pleural infections: leaving reluctance behind.

    Porcel JM

    The European respiratory journal 2019; (54(2)) doi:10.1183/13993003.01001-2019.

    PMID: 31371440
  10. 10

    [Endoscopic surgery accelerates recovery from empyema].

    Nummi A, Räsänen J, Kauppi J, et al.

    Duodecim; laaketieteellinen aikakauskirja 2015; (131(7)):657-62.

    PMID: 26233983
  11. 11

    Video-assisted thoracoscopic decortication for the management of late stage pleural empyema, is it feasible?

    Hajjar WM, Ahmed I, Al-Nassar SA, et al.

    Annals of thoracic medicine 2016; (11(1)):71-8 doi:10.4103/1817-1737.165293.

    PMID: 26933461
  12. 12

    Thoracoscopy in stage 3 empyema thoracis in children - A safe and feasible alternative to thoracotomy.

    Santanakrishnan R, Murali GS, Javaregowda D, et al.

    Journal of pediatric surgery 2020; (55(4)):756-760 doi:10.1016/j.jpedsurg.2019.08.007.

    PMID: 31493886
  13. 13

    Open pleural decortication for the late stage empyema thoracis in children: a retrospective observational study from a tertiary hospital of eastern Nepal.

    Jaiswal LS, Pandit N, Sah B, Prasad JN

    Tropical doctor 2020; (50(3)):203-209 doi:10.1177/0049475520921279.

    PMID: 32345149
  14. 14

    Uniportal Thoracoscopic Debridement for Children With Refractory Pleural Empyema: Case Series of 21 Patients.

    Huang JX, Chen Q, Hong SM, et al.

    Frontiers in pediatrics 2021; (9()):777324 doi:10.3389/fped.2021.777324.

    PMID: 34900876
  15. 15

    A meta-analysis of video-assisted thoracoscopic decortication versus open thoracotomy decortication for patients with empyema.

    Pan H, He J, Shen J, et al.

    Journal of thoracic disease 2017; (9(7)):2006-2014 doi:10.21037/jtd.2017.06.109.

    PMID: 28840000
  16. 16

    Outcomes of adult empyema thoracis cases managed in a tertiary hospital in Uganda: a retrospective cohort study.

    Mwesige M, Otim P, Iranya RN, et al.

    BMC pulmonary medicine 2025; (25(1)):365 doi:10.1186/s12890-025-03861-0.

    PMID: 40751256
  17. 17

    Outcome of Pleural Empyema Treated With Video-Assisted Thoracoscopic Surgery in Patients With Severe Co-Morbidities: An Observational Study.

    Vu HA, Nguyen NV, Le TD, et al.

    Medical devices (Auckland, N.Z.) 2025; (18()):87-96 doi:10.2147/MDER.S498901.

    PMID: 39906171
  18. 18

    Video-assisted thoracoscopic surgery and open chest surgery in infectious lung diseases.

    Thirugnanam A

    Journal of visualized surgery 2017; (3()):3 doi:10.21037/jovs.2016.12.03.

    PMID: 29078566
  19. 19

    Decortication with uniport video-assisted thoracoscopic surgery for empyema due to postoperative esophageal leakage: a report of two pediatric cases.

    Goto Y, Ogata S, Shimizu H, et al.

    Surgical case reports 2024; (10(1)):247 doi:10.1186/s40792-024-02049-8.

    PMID: 39466453
  20. 20

    Intrapleural Fibrinolytic Therapy versus Early Medical Thoracoscopy for Treatment of Pleural Infection. Randomized Controlled Clinical Trial.

    Kheir F, Thakore S, Mehta H, et al.

    Annals of the American Thoracic Society 2020; (17(8)):958-964 doi:10.1513/AnnalsATS.202001-076OC.

    PMID: 32421353
  21. 21

    Does the time to diagnosis and treatment influence outcome in adults with pleural infections.

    Klausen MB, Laursen C, Bendixen M, et al.

    European clinical respiratory journal 2023; (10(1)):2174645 doi:10.1080/20018525.2023.2174645.

    PMID: 36743828
  22. 22

    Association between serial changes in serum C-reactive protein levels and mortality among patients with pleural empyema: a database research.

    Shiroshita A, Takeshita M, Nishiuma T, et al.

    BMC pulmonary medicine 2025; (25(1)):337 doi:10.1186/s12890-025-03799-3.

    PMID: 40652250
  23. 23

    Parapneumonic Effusion Versus Pulmonary Empyema in Children: Analysis of Risk Factors and Laboratory Predictors Through a Single Center Experience.

    Improta M, Morlino F, Ragucci R, et al.

    Children (Basel, Switzerland) 2025; (12(8)) doi:10.3390/children12081103.

    PMID: 40868554

This page is for informational purposes only and does not replace professional medical advice. Always consult your pulmonologist or thoracic surgeon to discuss the most appropriate pleural empyema treatment plan for your specific situation.

Get notified when new evidence is published on Pleural empyema.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.